 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ResMed Inc. (NYSE:RMD  Get Free Report) has been given an average recommendation of Moderate Buy by the ten brokerages that are currently covering the firm, Marketbeat.com...

ResMed Inc. (NYSE:RMD) Receives $248.29 Consensus Target Price from Analysts

In afternoon trading on Tuesday, Healthcare stocks are the best performing sector, losing just 0.5%. Within that group, ResMed Inc...

Tuesday Sector Leaders: Healthcare, Consumer Products

Unpacking the Growth and Competitive Edges of ResMed Inc (RMD)Related Stocks: RMD...

ResMed Inc (RMD): A Deep Dive into Financial Metrics and Competitive Strengths

Discovering the True Worth of ResMed Inc (RMD)Related Stocks: RMD...

ResMed (RMD)'s Hidden Bargain: An In-Depth Look at the 25% Margin of Safety Based on its Valuation

In early trading on Tuesday, shares of ResMed topped the list of the days best performing components of the S&amp;P 500 index, trading up 3.4%. Year to date, ResMed has lost about 31.3% of...

Video: S&amp;P 500 Movers: NDSN, RMD

DNB Asset Management AS cut its stake in ResMed Inc. (NYSE:RMD  Free Report) by 1.5% in the second quarter, according to the company in its most recent disclosure with the Securities and...

DNB Asset Management AS Cuts Stock Holdings in ResMed Inc. (NYSE:RMD)

DNB Asset Management AS reduced its stake in ResMed Inc. (NYSE:RMD  Free Report) by 1.5% during the second quarter, according to its most recent filing with the Securities and Exchange...

DNB Asset Management AS Decreases Stake in ResMed Inc. (NYSE:RMD)

ResMed Inc. (NYSE:RMD  Free Report)  Investment analysts at Zacks Research lifted their FY2026 earnings estimates for ResMed in a report released on Friday, September 22nd. Zacks...

Zacks Research Research Analysts Raise Earnings Estimates for ResMed Inc. (NYSE:RMD)

Birch Capital Management LLC lowered its position in shares of ResMed Inc. (NYSE:RMD  Free Report) by 0.5% during the 2nd quarter, Holdings Channel.com reports. The firm owned 25,948 shares of...

Birch Capital Management LLC Decreases Stock Position in ResMed Inc. (NYSE:RMD)

Capricorn Fund Managers Ltd acquired a new position in shares of ResMed Inc. (NYSE:RMD  Free Report) during the second quarter, according to its most recent filing with the Securities &#38...

Capricorn Fund Managers Ltd Purchases New Stake in ResMed Inc. (NYSE:RMD)

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the Sleep and Respiratory Care and Software as a Service segments. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment provides business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.

Watchers	1,456
52-Wk Low	$136.20
52-Wk High	$243.52

Market Cap	$22.07B
Volume (M)	185,144.00
52-Wk High	$243.52
52-Wk Low	$136.20

RMD Resmed Inc.

About

Feed

News

Sentiment

Earnings

Fundamentals